Asteran is a premier preclinical contract research organization (CRO) dedicated to advancing scientific discovery and supporting the development of innovative therapeutics. With a focus on oncology, dermatology, inflammation, and pharmacology, we offer a comprehensive suite of services that includes pharmacology, toxicology, and specialized preclinical models. Our team of experienced scientists is committed to delivering high-quality, reliable data that enables our clients to navigate the complexities of drug development with confidence.
At Asteran, we pride ourselves on our ability to provide customized and hypothesis-driven studies, utilizing cutting-edge technologies and validated models. From GLP-compliant toxicology and pharmacokinetic studies to advanced oncology models such as xenografts and immunotherapy, we cover all stages of preclinical research. Our innovative approaches, combined with digital data collection systems and regulatory-ready reporting tools like StarTox, ensure that our clients receive the most accurate and actionable insights.
We are driven by scientific excellence and a passion for accelerating the development of life-changing therapies. Whether you’re exploring novel oncology treatments, dermatology therapeutics, or immune-mediated disease solutions, Asteran’s expertise and state-of-the-art capabilities are here to guide you every step of the way.